Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Exploring biomarkers related to coagulation and immunity in myocardial infarction based on bioinformatics.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; In Process
    • Publication Information:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • Abstract:
      Declarations. Competing interests: The authors declare no conflicts of interest. Ethics approval and consent to participate: The study received approval from Shanghai Gongli Hospital Ethics Committee (approval number: GLYYls2024-075) and written informed consent was obtained from all participants (or their legal guardians where applicable). All research was conducted in accordance with the Declaration of Helsinki, and all methods were performed in accordance with the relevant guidelines and regulations.The authors declare no conflicts of interest. Informed consent: Informed consent was obtained from all patients prior to their participation in the trial.
    • References:
      Am J Med. 2022 Dec;135(12):1401-1409. (PMID: 36075485)
      Autoimmun Rev. 2016 Aug;15(8):856-8. (PMID: 27079498)
      J Cell Mol Med. 2024 Feb;28(3):e18086. (PMID: 38152044)
      J Mol Cell Cardiol. 2005 Apr;38(4):617-23. (PMID: 15808838)
      Blood. 2024 Jun 6;143(23):2425-2432. (PMID: 38498041)
      Int J Mol Sci. 2022 Dec 25;24(1):. (PMID: 36613770)
      Nat Rev Cardiol. 2023 Jun;20(6):373-385. (PMID: 36627513)
      Eur J Immunol. 1999 Mar;29(3):1004-13. (PMID: 10092105)
      J Cell Physiol. 2020 Apr;235(4):3539-3547. (PMID: 31584202)
      Front Immunol. 2022 Dec 22;13:1061800. (PMID: 36618351)
      Oxid Med Cell Longev. 2018 Mar 18;2018:1975167. (PMID: 29743973)
      Pharmacol Rev. 2020 Jan;72(1):1-49. (PMID: 31767622)
      Front Cardiovasc Med. 2022 Jul 25;9:939972. (PMID: 35958412)
      Circ Res. 2015 Jan 16;116(2):307-11. (PMID: 25593275)
      Food Chem Toxicol. 2019 May;127:31-41. (PMID: 30844438)
      Mol Cell Biochem. 2019 Jan;451(1-2):69-78. (PMID: 29971544)
      J Leukoc Biol. 2024 Dec 31;117(1):. (PMID: 38478636)
      J Cardiol. 2023 Feb;81(2):168-178. (PMID: 35882613)
      Int J Mol Sci. 2023 Aug 08;24(16):. (PMID: 37628744)
      J Physiol. 2018 Jun;596(12):2345-2358. (PMID: 29604078)
      Front Immunol. 2022 Sep 23;13:985280. (PMID: 36211334)
      Mol Cell. 2020 Apr 2;78(1):9-29. (PMID: 32243832)
      J Am Coll Cardiol. 2021 Apr 20;77(15):1871-1874. (PMID: 33858623)
      Front Immunol. 2022 Oct 28;13:984480. (PMID: 36389763)
      J Cell Biochem. 2015 Jun;116(6):1113-20. (PMID: 25536374)
      J Clin Invest. 2022 Dec 15;132(24):. (PMID: 36194491)
      J Clin Med. 2023 Feb 09;12(4):. (PMID: 36835934)
      Blood. 2022 Mar 3;139(9):1269-1271. (PMID: 35238893)
      Genes Dev. 1994 Dec 15;8(24):2953-63. (PMID: 8001817)
      Cent Eur J Immunol. 2023;48(2):111-125. (PMID: 37692032)
      Front Immunol. 2024 Feb 27;15:1385966. (PMID: 38476225)
      Egypt Heart J. 2022 Dec 22;74(1):84. (PMID: 36547747)
      Nat Rev Cardiol. 2020 Aug;17(8):457-473. (PMID: 32231331)
      J Neuroinflammation. 2023 Jan 23;20(1):13. (PMID: 36691064)
      Int J Med Sci. 2017 Sep 30;14(12):1284-1291. (PMID: 29104486)
      Semin Cell Dev Biol. 2014 Apr;28:12-21. (PMID: 24631356)
      J Psychiatry Neurosci. 2000 Jan;25(1):33-42. (PMID: 10721682)
      Biomolecules. 2022 Oct 25;12(11):. (PMID: 36358907)
      Blood. 2019 Feb 7;133(6):511-520. (PMID: 30523120)
      Nat Rev Mol Cell Biol. 2021 May;22(5):346-366. (PMID: 33504982)
      Circ Res. 2020 Aug 14;127(5):664-676. (PMID: 32434457)
      J Clin Med. 2023 Feb 06;12(4):. (PMID: 36835825)
      Eur Heart J. 2021 Apr 7;42(14):1289-1367. (PMID: 32860058)
      Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E306-14. (PMID: 16825605)
      Circulation. 2023 Jun 13;147(24):1823-1842. (PMID: 37158107)
      iScience. 2024 Jun 14;27(7):110275. (PMID: 39040073)
      J Transl Med. 2023 Mar 6;21(1):176. (PMID: 36879254)
      PeerJ. 2023 May 16;11:e15058. (PMID: 37214088)
      Int J Mol Sci. 2022 May 06;23(9):. (PMID: 35563605)
      Blood. 2012 Aug 2;120(5):933-46. (PMID: 22496157)
      Signal Transduct Target Ther. 2023 Oct 13;8(1):394. (PMID: 37828006)
      Cardiovasc Res. 2023 May 2;119(3):772-785. (PMID: 35950218)
      PeerJ. 2023 Oct 3;11:e16122. (PMID: 37810795)
      Stroke. 2012 Dec;43(12):3305-12. (PMID: 23150653)
      J Mol Endocrinol. 2008 Aug;41(2):65-74. (PMID: 18495691)
      J Transl Med. 2023 Mar 27;21(1):223. (PMID: 36973787)
      J Parkinsons Dis. 2022;12(1):267-282. (PMID: 34633332)
      J Pers Med. 2022 Feb 12;12(2):. (PMID: 35207757)
      Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):709-725. (PMID: 29437578)
      Semin Thromb Hemost. 2019 Feb;45(1):86-93. (PMID: 30634198)
    • Grant Information:
      PKJ2024-Y28 Science and Technology Development Fund for Public Welfare Research Projects in Public Institutions of Shanghai Pudong New Area; PWZxq2022-12 Commission(PWRd2022-04).Discipline Construction Project of Shanghai Pudong New Area Health Commission (Key Discipline Group); PWRd2022-04 The Training Plan of discipline Leader of Shanghai Pudong new area Health Commission
    • Publication Date:
      Date Created: 20251119 Latest Revision: 20251122
    • Publication Date:
      20260130
    • Accession Number:
      PMC12630877
    • Accession Number:
      10.1038/s41598-025-24313-z
    • Accession Number:
      41258366